WMSA
RPTP

Weiss Multi-Strategy Advisers’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-22,000
Closed -$200K – 1135
2014
Q1 		$220K Buy
22,000
+8,210
+60% +$119K ﹤0.01% 894
2013
Q4 		$180K Buy
+13,790
New +$190K ﹤0.01% 918

Other funds holding RPTP

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Weiss Multi-Strategy Advisers's RPTP Position: Q2 2014 in Review

Weiss Multi-Strategy Advisers sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q2 2014, closing a stake of 22,000 shares — an estimated $200K sold.

Weiss Multi-Strategy Advisers first reported a position in RPTP in Q4 2013 and held it in 2 quarters. The position peaked at $220K in Q1 2014. 74 funds tracked by Wall St. Rank hold RPTP as of Q2 2014.

  • Weiss Multi-Strategy Advisers reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q2 2014 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 22,000 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q2 2014, an estimated $200K.
  • Weiss Multi-Strategy Advisers first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q4 2013 and held it in 2 quarters.
  • Weiss Multi-Strategy Advisers's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $220K in Q1 2014.
  • 74 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q2 2014.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2014, filed 14 Aug 2014.